refractory gastric cancer

Interviews and expert commentary tagged “refractory gastric cancer” — the latest oncology research and clinical practice from the Audio Journal of Oncology.

Cabozantinib Improved Hepatocellular Carcinoma Survival Beyond Sorafenib
Audio Journal of Oncology

Cabozantinib Improved Hepatocellular Carcinoma Survival Beyond Sorafenib

BARCELONA—Oral cabozantinib “significantly improved” overall survival (OS) and progression free survival (PFS) compared to placebo in patients with advanced hepatocellular carcinoma(HCC) w

15 October 2018
8 mins